课题基金 / 基金详情

LIVER TUMOR PROMOTION IN SPARSE FUR MUTANT MICE

LIVER TUMOR PROMOTION IN SPARSE FUR MUTANT MICE
稀疏毛皮突变小鼠的肝脏肿瘤促进
批准号:
2096419
负责人:
DITTAKAVI S SARMA
金额:
$10.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-10 至 1995-04-30

项目摘要

项目成果

DITTAKAVI S SARMA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term goal of the present proposal is to determine whether metabolic and genetic disorders that are associated with increased levels of orotic acid are at a higher risk of tumor promotion. The rationale for this stems from our observations: (i) orotic acid, a normal cellular constituent is a multi-organ tumor promoter, (ii) being a precursor of pyrimidine nucleotides, exposure to orotic acid results in increased levels of uridine nucleotides and creation of such an imbalance in nucleotide pools is essential for orotic acid to exert its tumor promoting effect; and (iii) feeding a diet deficient in arginine, a urea cycle amino acid induces disturbances in urea cycle, and such perturbations not only result in increased levels of orotic acid and hepatic uridine nucleotides but also exert tumor promoting effect in the livers of both rats and mice. Sparse fur mutant (spf/y) mice are 90% deficient in ornithine transcarbamylase (OTC) a urea cycle enzyme. This deficiency is associated with high levels of orotic acid and an imbalance in hepatic nucleotide pools. We propose to use these mutant mice as a model system to examine the question whether metabolic and genetic disorders associated with higher levels of orotic acid and uridine nucleotides post increased risk of tumor promotion. In the proposed study, both mutant male mice and the normal counterparts, Swiss ICR male mice will be exposed to liver carcinogens at doses which by themselves do not induce liver cell cancer in the normal mice unless promoted. It is anticipated that initiated sparse fur mutant mice which have higher levels of orotic acid will develop hepatocellular carcinoma even in the absence of any exogenous tumor promoter, while the initiated normal controls will not develop unless exposed to exogenous promoter. In the next series we will determine whether such cancer incidence can be decreased by administering phosphonylacetyl-L-aspartic acid and adenine which inhibit the synthesis of orotic acid and its conversion to uridine nucleotides respectively. This experiment should indicate whether the increased susceptibility of spf/y mice to carcinogen-induced tumorigenesis is because of high levels of orotic acid and the associated imbalance in nucleotide pools or due to some other abnormality associated with the mutant mice.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Nucleotide pool imbalances in the livers of patients with urea cycle disorders associated with increased levels of orotic aciduria.
尿素循环障碍患者肝脏中的核苷酸池失衡与乳清酸尿水平升高相关。
DOI: --
发表时间: 1995
期刊: Biochemistry and molecular biology international.
影响因子: --
作者: [Vasudevan,S, Qureshi,IA, Lambert,M, Rao,PM, Rajalakshmi,S, Sarma,DS]
通讯作者: Sarma,DS
Regulation of orotic acid biosynthesis and excretion induced by oral glutamine administration in mice.
小鼠口服谷氨酰胺诱导的乳清酸生物合成和排泄的调节。
DOI: 10.1006/bmmb.1993.1035
发表时间: 1993
期刊: Biochemical medicine and metabolic biology
影响因子: --
作者: [Nelson,J, Qureshi,IA, Ghole,VS, Deshmukh,DR]
通讯作者: Deshmukh,DR
Perturbations of endogenous levels of orotic acid and carcinogenesis: effect of an arginine-deficient diet and carbamyl aspartate on hepatocarcinogenesis in the rat and the mouse.
乳清酸内源水平的扰动和致癌作用:缺乏精氨酸的饮食和氨甲酰天冬氨酸对大鼠和小鼠肝癌发生的影响。
DOI: 10.1093/carcin/15.11.2497
发表时间: 1994
期刊: Carcinogenesis
影响因子: 4.7
作者: [Vasudevan,S, Laconi,E, Rao,PM, Rajalakshmi,S, Sarma,DS]
通讯作者: Sarma,DS
The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
各种抑制剂对鸟氨酸转氨甲酰酶缺陷的稀疏毛突变小鼠(spf/Y)乳清酸排泄调节的影响。
DOI: 10.1016/0009-2797(93)03195-z
发表时间: 1993
期刊: Chemico-biological interactions
影响因子: 5.1
作者: [Nelson,J, Qureshi,IA, Vasudevan,S, Sarma,DS]
通讯作者: Sarma,DS
IVER TUMOR PROMOTION IN SPARSE FUR MUTANT MICE
  • 批准号:
    3199680
  • 项目类别:
  • 资助金额:
    $10.58万
  • 财政年份:
    1992
  • 负责人:
    DITTAKAVI S SARMA
  • 依托单位:
LIVER TUMOR PROMOTION IN SPARSE FUR MUTANT MICE
  • 批准号:
    3199681
  • 项目类别:
  • 资助金额:
    $10.26万
  • 财政年份:
    1992
  • 负责人:
    DITTAKAVI S SARMA
  • 依托单位:
CELL PROLIFERATION & LIVER CARCINOGENESIS
  • 批准号:
    3189476
  • 项目类别:
  • 资助金额:
    $5.6万
  • 财政年份:
    1988
  • 负责人:
    DITTAKAVI S SARMA
  • 依托单位:
CELL PROLIFERATION & LIVER CARCINOGENESIS
  • 批准号:
    3189474
  • 项目类别:
  • 资助金额:
    $5.47万
  • 财政年份:
    1988
  • 负责人:
    DITTAKAVI S SARMA
  • 依托单位:
海外基金